The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Evidence that anti–tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report
Abstract
Objective: Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF) antagonists is highly effective, but their mechanisms of action are not completely clear. Since anti‐TNF therapy induces a decrease in synovial cellularity, this study focused on the modulation of RA synovial apoptosis following treatment with either soluble TNF receptor (etanercept) or TNF chimeric monoclonal antibody (infliximab). Methods: Apoptosis (TUNEL and active caspase 3 staining) and cell surface markers were evaluated by immunohistochemistry in synovial biopsy samples obtained before and after 8 weeks of treatment with etanercept (12 patients) or infliximab (9 patients). We also determined by flow cytometry the in vitro effect of etanercept and infliximab on apoptosis of RA mononuclear cells derived from the synovial fluid (SF) and peripheral blood (PB). Results: Eight weeks of treatment with etanercept and with infliximab significantly increased synovial apoptosis. This change was accompanied by a significant decrease in the synovial monocyte/macrophage population. The decrease in lymphocyte numbers did not reach statistical significance. In vitro, 24 hours of incubation with either etanercept or infliximab induced apoptosis of the SF monocyte/macrophage population. PB monocyte/macrophages were less susceptible to anti‐TNF–mediated apoptosis. No changes in the rate of apoptosis were observed in the lymphocyte population derived from either SF or PB. Conclusion: In RA patients, both etanercept and infliximab are able to induce cell type–specific apoptosis in the monocyte/macrophage population. This suggests a potential pathway that would account for the diminished synovial inflammation and the decreased numbers of synovial macrophages evident after TNF blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
van Gestel, A. M., Prevoo, M. L. L., van't Hof, M. A., van Rijswijk, M. H., van de Putte, L. B. A., & van Riel, P. L. C. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390105 · Cited by 1,572
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Lügering, A., Schmidt, M., Lügering, N., Pauels, H.-G., Domschke, W., & Kucharzik, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.28702 · Cited by 588
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
ten Hove, T. (2002) · Gut · doi:10.1136/gut.50.2.206 · Cited by 545
Apoptosis as a therapeutic tool in rheumatoid arthritis
Pope, R. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri846 · Cited by 401
Tak, P. P., Taylor, P. C., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E., & Maini, R. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390702 · Cited by 377
Detection of apoptosis in tissue sections
Stadelmann, C., & Lassmann, H. (2000) · Cell and Tissue Research · doi:10.1007/s004410000203 · Cited by 250
Smeets, T. J. M., Kraan, M. C., van Loon, M. E., & Tak, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11098 · Cited by 224
Apoptosis in rheumatoid arthritis
Baier, A., Meineckel, I., Gay, S., & Pap, T. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00015 · Cited by 207
Suffredini, A. F., Reda, D., Banks, S. M., Tropea, M., Agosti, J. M., & Miller, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5038 · Cited by 205
Apoptosis in rheumatoid arthritis
Tak, P. P., & Firestein, G. S. (1999) · Apoptosis and Inflammation · doi:10.1007/978-3-0348-8741-0_9 · Cited by 200
Watts, A. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2119 · Cited by 195
Di Sabatino, A. (2004) · Gut · doi:10.1136/gut.53.1.70 · Cited by 186
Catrina, A. I. (2002) · Rheumatology · doi:10.1093/rheumatology/41.5.484 · Cited by 181
Self-citationBrennan, F. M., Browne, K. A., Green, P. A., Jaspar, J. M., Maini, R. N., & Feldmann, M. (1997) · Rheumatology · doi:10.1093/rheumatology/36.6.643 · Cited by 179
The Role of TNFα and IL-1 in Rheumatoid Arthritis
Feldmann, M., Brennan, F. M., Foxwell, B. M. J., & Maini, R. M. (2000) · Current Directions in Autoimmunity · doi:10.1159/000060522 · Cited by 173
Ulfgren, A. K., Lindblad, S., Klareskog, L., Andersson, J., & Andersson, U. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.8.654 · Cited by 173
Self-citationPagliari, L. J., Perlman, H., Liu, H., & Pope, R. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8855-8865.2000 · Cited by 150
Morita, Y., Yamamura, M., Kawashima, M., Harada, S., Tsuji, K., Shibuya, K., Maruyama, K., & Makino, H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1669::aid-art19>3.0.co;2-g · Cited by 142
Studies of T-cell activation in chronic inflammation.
Cope, A. P. (2002) · Arthritis Research · doi:10.1186/ar557 · Cited by 137
Quantification of the cell infiltrate in synovial tissue by digital image analysis
Kraan, M. C., Haringman, J. J., Ahern, M. J., Breedveld, F. C., Smith, M., & Tak, P. P. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.1.43 · Cited by 133
van Deventer, S. J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.29035 · Cited by 128
Berg, L., Lampa, J., Rogberg, S., van Vollenhoven, R., & Klareskog, L. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.2.133 · Cited by 88
Self-citationAnti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
Ferran, C. J., Dautry, F., Merite, S., Sheehan, K. C. F., Schreiber, R. D., Grau, G. E., Bach, J., & Chatenoud, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117215 · Cited by 77
Role of nuclear factor κb in synovial inflammation
Müller‐Ladner, U., Gay, R. E., & Gay, S. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0066-1 · Cited by 66
Synovial tissue response to treatment with campath‐1h
Ruderman, E., Weinblatt, M. E., Thurmond, L. M., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380215 · Cited by 54
Frishman, J. I., Edwards, C. K., Sonnenberg, M. G., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/317605 · Cited by 36
The Fas-FasL death receptor and PI3K pathways independently regulate monocyte homeostasis
Perlman, H., Pagliari, L. J., Nguyen, N. N., Bradley, K., Liu, H., & Pope, R. M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2421::aid-immu2421>3.0.co;2-w · Cited by 36
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Self-citationTumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Neutrophil function in inflammation and inflammatory diseases
Wright, H. L., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2010) · Rheumatology · doi:10.1093/rheumatology/keq045 · Cited by 761
Metadata
- Authors
- Catrina, A. I., Trollmo, C., af Klint, E., Engstrom, M., Lampa, J., Hermansson, Y., Klareskog, L., & Ulfgren, A. K.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 52
- Issue
- 1
- Pages
- 61-72
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039597867
- Cited by
- 255
- References
- 41
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.